Circulating soluble urokinase plasminogen activator receptor is stably elevated during the first week of treatment in the intensive care unit and predicts mortality in critically ill patients
about
Usefulness of suPAR as a biological marker in patients with systemic inflammation or infection: a systematic reviewCirculating Permeability Factors in Primary Focal Segmental Glomerulosclerosis: A Review of Proposed CandidatessuPAR as a prognostic biomarker in sepsisGlomerular diseases: FSGS.What was old is new again: using the host response to diagnose infectious disease.Increased liver stiffness denotes hepatic dysfunction and mortality risk in critically ill non-cirrhotic patients at a medical ICUUrokinase-type plasminogen activator receptor (uPAR) ligation induces a raft-localized integrin signaling switch that mediates the hypermotile phenotype of fibrotic fibroblastsClinical value of plasma soluble urokinase-type plasminogen activator receptor levels in term neonates with infection or sepsis: a prospective study.Unchanged plasma levels of the soluble urokinase plasminogen activator receptor in elective coronary artery bypass graft surgery patients and cardiopulmonary bypass useUrinary soluble urokinase receptor levels are elevated and pathogenic in patients with primary focal segmental glomerulosclerosisUrokinase-type plasminogen activator receptor as a predictor of poor outcome in patients with systemic inflammatory response syndromePrognostic value of chromogranin A in severe sepsis: data from the FINNSEPSIS study.Urine soluble urokinase-type plasminogen activator receptor levels correlate with proteinuria in Puumala hantavirus infectionElevated circulating soluble interleukin-2 receptor in patients with chronic liver diseases is associated with non-classical monocytesUtility of the plasma level of suPAR in monitoring risk of mortality during TB treatmentCirculating microRNA-150 serum levels predict survival in patients with critical illness and sepsis.Plasma levels of soluble urokinase-type plasminogen activator receptor associate with the clinical severity of acute Puumala hantavirus infectionCirculating microRNA-223 serum levels do not predict sepsis or survival in patients with critical illness.Developments for improved diagnosis of bacterial bloodstream infections.Detection of suPAR in the Saliva of Healthy Young Adults: Comparison with Plasma Levels.Are there new approaches for diagnosis, therapy guidance and outcome prediction of sepsis?Increased Soluble Urokinase-Type Plasminogen Activator Receptor (suPAR) Levels in Plasma of Suicide Attempters.Persistently elevated osteopontin serum levels predict mortality in critically ill patients.The Prognostic Value of suPAR Compared to Other Inflammatory Markers in Patients with Severe Sepsis.Why high suPAR is not super--diagnostic, prognostic and potential pathogenic properties of a novel biomarker in the ICU.Soluble urokinase-type plasminogen activator receptor levels in patients with burn injuries and inhalation trauma requiring mechanical ventilation: an observational cohort studyPrognostic significance of APACHE II score and plasma suPAR in Chinese patients with sepsis: a prospective observational study.Serum soluble urokinase-type plasminogen activator receptor as a biological marker of bacterial infection in adults: a systematic review and meta-analysis.Circulating suPAR in two cohorts of primary FSGS.Plasma suPAR levels are associated with mortality, admission time, and Charlson Comorbidity Index in the acutely admitted medical patient: a prospective observational study.Risk assessment in sepsis: a new prognostication rule by APACHE II score and serum soluble urokinase plasminogen activator receptor.Serum Levels of TNF Receptor Ligands Are Dysregulated in Sepsis and Predict Mortality in Critically Ill PatientsSoluble urokinase plasminogen activation receptor--An emerging new biomarker of cardiovascular disease and critical illness.Regulation and prognostic relevance of symmetric dimethylarginine serum concentrations in critical illness and sepsis.Serum soluble urokinase-type plasminogen activator receptor levels and idiopathic FSGS in children: a single-center reportU6 is unsuitable for normalization of serum miRNA levels in patients with sepsis or liver fibrosis.Acute Changes in Inflammatory Biomarker Levels in Recreational Runners Participating in a Marathon or Half-MarathonSerum levels of S100A6 are unaltered in patients with resectable cholangiocarcinoma.High prevalence of Y-box protein-1/p18 fragment in plasma of patients with malignancies of different origin.Correlation of biomarkers for parasite burden and immune activation with acute kidney injury in severe falciparum malaria
P2860
Q24614787-04D48A80-4CD5-4546-9675-7AA34CF139FAQ26747221-470C19CC-C0B2-4B6A-BB2B-A4013C082995Q26858996-24C86009-277D-4382-B411-8FF732E2B79AQ27687257-CA439698-AE3D-46B8-AFD6-AC2CACD80502Q30376327-023A36D9-82C6-49EC-A604-5D532D736EA0Q30465982-22BB4F1E-AC23-419F-88A2-074D6B7DE048Q33556249-A98DA790-7D75-47DB-A2B8-A72194FAD08BQ33634943-FFC5D32D-0568-4184-B273-8EF7C5FCB0A0Q33727193-D395C135-DFB6-473A-B112-FA468FD19604Q33783271-51534E8D-2B0B-41CE-B60C-3D007760FC72Q34032235-BDA93B79-F7E0-4082-B6A5-ADB1465C8C85Q34227666-6BF0E550-5A4F-44CE-9A48-8A9889C3B0FAQ34231973-9158681D-B40E-456C-B6C3-5992B8D9DFC0Q34244205-7E6D94F5-42F4-466F-9438-7F4E71AFB910Q34399577-6A22B8F5-AD5B-45BB-A535-697AD619E1D5Q34571235-3F691299-4C1F-47AC-8BD0-9E7A53926A4FQ34976988-5E1B05F4-8CFA-4E20-828C-1D89484DF185Q35163820-74327C10-7E5F-4EC6-AA91-191095E82CFBQ35171979-C825ECCF-47D4-46E0-BFC8-DE520D7A438FQ35534951-473F041B-A9A9-4120-BCF8-23A4ED2F7F64Q35622257-BC08BA33-E8CE-4FAD-93CB-5EE0D92892E7Q35801533-19E68616-9E30-4D4E-8487-A7C4F52684D8Q35814641-308B241D-F318-471D-97B1-3BF3FEB4BC60Q35896513-FDB794F9-9854-45B3-9C54-83037420DC67Q36073143-67CB452D-DA14-4FE8-9EB1-B3311795474EQ36073215-BF87CE1A-232B-4D92-8B5C-99343E46B46FQ36090003-E5775332-C53E-4B45-9785-02EABFC88BE0Q36227804-6305B90D-9221-4659-83B3-147E56F4B4CDQ36426091-13A8E776-522D-4A2A-8145-6527E84750B8Q36633905-65A702CF-075C-4F54-822D-E27E7A350C37Q36633993-35B3B2B8-223F-4D5B-AD29-92336C7E9E0CQ36848839-F632FF84-04E5-4B6C-9C22-22CFAE04DE7FQ36987888-806B268E-5129-4A77-8C02-6FFC7AE528A4Q37015522-F956AD2A-A78D-4570-B959-22D72102FCA7Q37065608-E128711B-ABF0-412F-941A-330D0A37729CQ37212187-CDC8CB34-62CE-4EF4-AA0E-B49789E471FDQ37218861-B7DB3100-5623-4311-B683-CA417DD721FDQ37314018-D03B2620-D88E-41A0-B090-B8B030AB3B82Q37539656-4AADC9AE-32BD-4158-B540-8D2DFC7EE25CQ37716666-C0530801-20EF-43A2-ACCB-BB3167706316
P2860
Circulating soluble urokinase plasminogen activator receptor is stably elevated during the first week of treatment in the intensive care unit and predicts mortality in critically ill patients
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Circulating soluble urokinase ...... ity in critically ill patients
@ast
Circulating soluble urokinase ...... ity in critically ill patients
@en
type
label
Circulating soluble urokinase ...... ity in critically ill patients
@ast
Circulating soluble urokinase ...... ity in critically ill patients
@en
prefLabel
Circulating soluble urokinase ...... ity in critically ill patients
@ast
Circulating soluble urokinase ...... ity in critically ill patients
@en
P2093
P2860
P356
P1433
P1476
Circulating soluble urokinase ...... ity in critically ill patients
@en
P2093
Alexander Koch
Andreas Horn
Carsten Kruschinski
Christian Trautwein
Edouard Sanson
Eray Yagmur
Frank Tacke
Hanna Dückers
Henning Zimmermann
Sebastian Voigt
P2860
P2888
P356
10.1186/CC10037
P577
2011-02-16T00:00:00Z
P5875
P6179
1029080892